Beyond weight loss, semaglutide's efficacy extends to improving overall health markers, reducing risks for serious conditions like heart disease, stroke, and type 2 diabetes, cementing its place as a comprehensive health solution
Rothrock 2011
Card Fail Rev 3:711 Usman MS, Siddiqi TJ, Memon MM, Khan MS, Rawasia WF, Talha Ayub M, Sreenivasan J, Golzar Y (2018) Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: a systematic review and meta-analysis
It depends on the nature of the surgery and the patients recovery
That means clinicians and users rely heavily on mechanistic insight and clinical experience to manage the issue
Originally FDA-approved for type 2 diabetes, several now carry indications for weight management and cardiovascular risk reduction